Age and BRAF^V600E Mutation Stratified Patients with Cytologically Benign Thyroid Nodules

References

• Mulita F, Anjum F. Thyroid adenoma. In: StatPearls [Internet]. StatPearls Publishing; 2023.
   Google Scholar
• Bernet VJ, Chindris AM. Update on the Evaluation of thyroid nodules. J Nucl Med. 2021;62(Suppl 2):13S–19S. doi:10.2967/jnumed.120.246025
   PubMedGoogle Scholar
• Brito JP, Gionfriddo MR, Al Nofal A, et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(4):1253–1263.
   PubMed Web of Science ®Google Scholar
• Zhou J, Yin L, Wei X, et al. 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS. Endocrine. 2020;70(2):256–279. doi:10.1007/s12020-020-02441-y
   PubMed Web of Science ®Google Scholar
• Detweiler K, Elfenbein DM, Mayers D. Evaluation of thyroid nodules. Surg Clin North Am. 2019;99(4):571–586. doi:10.1016/j.suc.2019.04.001
   PubMed Web of Science ®Google Scholar
• Wong R, Farrell SG, Grossmann M. Thyroid nodules: diagnosis and management. Med J Aust. 2018;209(2):92–98. doi:10.5694/mja17.01204
   PubMed Web of Science ®Google Scholar
• Mulita F, Iliopoulos F, Tsilivigkos C, et al. Cancer rate of Bethesda category II thyroid nodules. Med Glas. 2022;19(1):1413–1421.
   Google Scholar
• Poller DN, Glaysher S. Molecular pathology and thyroid FNA. Cytopathology. 2017;28(6):475–481. doi:10.1111/cyt.12492
   PubMed Web of Science ®Google Scholar
• Hlozek J, Pekova B, Rotnágl J, Holý R, Astl J. Genetic changes in thyroid cancers and the importance of their preoperative detection in relation to the general treatment and determination of the extent of surgical intervention—a review. Biomedicines. 2022;10(7). doi:10.3390/biomedicines10071515
   PubMed Web of Science ®Google Scholar
• Pekova B, Sykorova V, Dvorakova S, et al. RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas. Thyroid. 2020;30(12):1771–1780. doi:10.1089/thy.2019.0802
   PubMed Web of Science ®Google Scholar
• Bulanova Pekova B, Sykorova V, Mastnikova K, et al. RET fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis. Endocr Relat Cancer. 2023;30(12). doi:10.1530/ERC-23-0117
   PubMed Web of Science ®Google Scholar
• Kim Y, Kim YS, Bae JS, Kim JS, Kim K. Is gross extrathyroidal extension to strap muscles (T3b) only a risk factor for recurrence in papillary thyroid carcinoma? A Propensity Score Matching Study. Cancers. 2022;14(10). doi:10.3390/cancers14102370
   Web of Science ®Google Scholar
• Chen H, Song A, Wang Y, et al. BRAF V600E mutation test on fine-needle aspiration specimens of thyroid nodules: clinical correlations for 4600 patients. Cancer Med. 2022;11(1):40–49. doi:10.1002/cam4.4419
   PubMed Web of Science ®Google Scholar
• Tao Y, Wang F, Shen X, et al. BRAF V600E status sharply differentiates lymph node metastasis-associated mortality risk in papillary thyroid cancer. J Clin Endocrinol Metab. 2021;106(11):3228–3238. doi:10.1210/clinem/dgab286
   PubMed Web of Science ®Google Scholar
• Lin K, Xiang Y, Qiao L, Liu R, Dong S, Zhang X. A predictive model for selecting malignant thyroid nodules in patients with nondiagnostic or indeterminate fine-needle aspiration cytologic findings. J Ultrasound Med. 2015;34(7):1245–1251. doi:10.7863/ultra.34.7.1245
   PubMed Web of Science ®Google Scholar
• Jinih M, Foley N, Osho O, et al. BRAF(V600E) mutation as a predictor of thyroid malignancy in indeterminate nodules: a systematic review and meta-analysis. Eur J Surg Oncol. 2017;43(7):1219–1227. doi:10.1016/j.ejso.2016.11.003
   PubMed Web of Science ®Google Scholar
• Chen X, Zhou Q, Wang F, et al. Value of BRAF V600E in high-risk thyroid nodules with benign cytology results. AJNR Am J Neuroradiol. 2018;39(12):2360–2365. doi:10.3174/ajnr.A5898
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim EK, Kwak JY, Moon HJ, Yoon JH. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method. Surgery. 2015;157(2):354–361. doi:10.1016/j.surg.2014.09.003
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu F, Shi H, et al. Predicting malignancy in thyroid nodules with benign cytology results: the role of Conventional Ultrasound, Shear Wave Elastography and BRAF V600E. Clin Hemorheol Microcirc. 2022;81(1):33–45. doi:10.3233/CH-211337
   PubMed Web of Science ®Google Scholar
• Gharib H, Papini E, Garber JR, et al. American association of clinical endocrinologists, American college of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules--2016 update. Endocr Pract. 2016;22(5):622–639. doi:10.4158/EP161208.GL
   PubMed Web of Science ®Google Scholar
• Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341–1346. doi:10.1089/thy.2017.0500
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200–4202. doi:10.1093/bioinformatics/btz210
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Bouchagier K, Anesidis S, Maroulis I, et al. Thyroidectomy for the management of differentiated thyroid carcinoma and their outcome on early postoperative complications: a 6-year single-centre retrospective study. Chirurgia. 2022;117(5):556–562.
   PubMed Web of Science ®Google Scholar
• Mulita F, Theofanis G, Verras G-I, et al. Comparison of postoperative bleeding using harmonic scalpel and LigaSure in thyroid surgery: a 15-year single-centre retrospective study. Medicinski Glasnik. 2023;20(2):1–6.
   Google Scholar
• Grimmichova T, Pacesova P, Hill M, et al. Thyroid cancer detection in a routine clinical setting: performance of ACR TI-RADS, FNAC, and molecular testing in prospective cohort study. Biomedicines. 2022;10(5):954.
   PubMed Web of Science ®Google Scholar
• Qi Q, Zhou A, Guo S, et al. Explore the diagnostic efficiency of Chinese thyroid imaging reporting and data systems by comparing with the other four systems (ACR TI-RADS, Kwak-TIRADS, KSThR-TIRADS, and EU-TIRADS): a Single-Center Study. Front Endocrinol. 2021;12. doi:10.3389/fendo.2021.763897
   Web of Science ®Google Scholar
• Mulita F, Plachouri M-K, Liolis E, Vailas M, Panagopoulos K, Maroulis I. Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS). Endokrynologia Polska. 2021;72(2):143–144. doi:10.5603/EP.a2021.0018
   PubMed Web of Science ®Google Scholar
• Du J, Han R, Chen C, et al. Diagnostic efficacy of ultrasound, cytology, and BRAFV600E mutation analysis and their combined use in thyroid nodule screening for papillary thyroid microcarcinoma. Front Oncol. 2022;11:4697.
   Web of Science ®Google Scholar
• Seo JY, Kim E-K, Kwak JY. Additional BRAF mutation analysis may have additional diagnostic value in thyroid nodules with “suspicious for malignant” cytology alone even when the nodules do not show suspicious US features. Endocrine. 2014;47(1):283–289.
   PubMed Web of Science ®Google Scholar
• Du J, Han R, Chen C, et al. Diagnostic efficacy of ultrasound, cytology, and BRAF(V600E) mutation analysis and their combined use in thyroid nodule screening for papillary thyroid microcarcinoma. Front Oncol. 2021;11:746776. doi:10.3389/fonc.2021.746776
   PubMed Web of Science ®Google Scholar
• Moon WJ, Choi N, Choi JW, Kim SK, Hwang TS. BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles. AJR Am J Roentgenol. 2012;198(3):668–674. doi:10.2214/AJR.11.7185
   PubMed Web of Science ®Google Scholar
• Li J, Liu J, Yu X, Bao X, Qian L. BRAFv600e mutation combined with thyroglobulin and fine-needle aspiration in diagnosis of lymph node metastasis of papillary thyroid carcinoma. Pathol Res Pract. 2018;214(11):1892–1897.
   PubMed Web of Science ®Google Scholar
• Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA. 2013;309(14). doi:10.1001/jama.2013.3190
   PubMed Web of Science ®Google Scholar
• Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol. 2015;33(1):42–50. doi:10.1200/jco.2014.56.8253
   PubMed Web of Science ®Google Scholar
• Shen X, Zhu G, Liu R, et al. Patient age–associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer. J Clin Oncol. 2018;36(5):438.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhao S, Shen X, et al. BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer. J Clin Oncol. 2018;36(27):2787.
   PubMed Web of Science ®Google Scholar
• Liang S, Huang K. Correlation between ultrasonographic appearance of papillary thyroid microcarcinoma and BRAF V600E mutation. J Oncol. 2022;2022. doi:10.1155/2022/5916379
   Web of Science ®Google Scholar
• Edge SB, Byrd DR, Carducci MA, Compton CC, Fritz A, Greene F. AJCC Cancer Staging Manual. Vol. 7. Springer; 2010.
   Google Scholar
• Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual. Vol. 1024. Springer; 2017.
   Google Scholar
• Adam MA, Thomas S, Hyslop T, Scheri RP, Roman SA, Sosa JA. Exploring the relationship between patient age and cancer-specific survival in papillary thyroid cancer: rethinking current staging systems. J Clin Oncol. 2016;34(36):4415–4420. doi:10.1200/JCO.2016.68.9372
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34. doi:10.1089/thy.2013.0367
   PubMed Web of Science ®Google Scholar
• Patton EE, Mitchell DL, Nairn RS. Genetic and environmental melanoma models in fish. Pigm Cell Melanoma Res. 2010;23(3):314–337. doi:10.1111/j.1755-148X.2010.00693.x
   PubMed Web of Science ®Google Scholar
• Maraka S, Janku F. BRAF alterations in primary brain tumors. Discov Med. 2018;26(141):51–60.
   PubMed Web of Science ®Google Scholar
• Angell TE, Lechner MG, Jang JK, Correa AJ, LoPresti JS, Epstein AL. BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration. Thyroid. 2014;24(9):1385–1393. doi:10.1089/thy.2014.0134
   PubMed Web of Science ®Google Scholar